The discovery of the BRCA1/NEAT1/miR-129-5p/WNT4 axis and the pivotal roles of WNT4 in WNT signaling activation as well as in the enhancement of BCSC generation suggest that WNT signaling is a potential therapeutic target for breast cancer with alterations in this signaling axis. This evidence concerns the gene NEAT1 and breast carcinoma.